drugset / Trial / NCT01263834

Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome

NCT01263834

Phase 2/3 Completed 39 enrolled Prince of Songkla University
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the adjunctive effect of intratenon Bevacizumab on the result of trabeculectomy in primary term of intraocular pressure (IOP).

Timeline

Start
2010-12
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 1.25 unknown Other
Comparator Mitomycin C Other / unclassified 0.4 mg/ml Other

Indications